Prognostic impact of <i>TP53</i> mutation in newly diagnosed diffuse large B‐cell lymphoma patients treated in the FIL‐DLCL04 trialAnnalisa Chiappella, Alice Di Rocco, Maurizio Martelli et al.|British Journal of Haematology|2021Cited by 39
Imatinib and ruxolitinib association: first experience in two patientsAlessandra Iurlo, Agostino Cortelezzi, Umberto Gianelli et al.|Haematologica|2014Cited by 29
Venetoclax-based regimens in octogenarian patients with CLL: efficacy, safety, and comparison to BTKi in a multicenter cohortAndrea Serafin, Andrea Visentin, Alessandro Cellini et al.|Blood Advances|2025Cited by 3
Real-World Venetoclax-Obinutuzumab in 232 Treatment Naive CLL Patients: Feasibility and TolerabilityAlessandra Tedeschi, Luca Laurenti, Andrea Galitzia et al.|Blood|2023Cited by 1